Revolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion in Peak Sales. Is the Stock Still a Buy After Skyrocketing More Than 5X?
The biotech's Rasonque is already available for prescription.
The biotech's Rasonque is already available for prescription.
BELLINGS Intelligence Score: 12
Why it matters
FDA approval of a biotech drug is a routine commercial milestone with limited direct impact on credit markets or broader financial conditions relevant to credit professionals.
Sources
The Motley Fool
Revolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion in Peak Sales. Is the Stock Still a Buy After Skyrocketing More Than 5X?
The biotech's Rasonque is already available for prescription.